Fusion Antibodies (FAB)

Sector:

Health Care

Index:

FTSE AIM All-Share

 55.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 142.50
  • 52 Week Low: 53.00
  • Currency: UK Pounds
  • Shares Issued: 26.01m
  • Volume: 7,461
  • Market Cap: £14.44m
  • RiskGrade: 464

Revenues rise, losses widen for Fusion Antibodies

By Josh White

Date: Monday 06 Dec 2021

LONDON (ShareCast) - (Sharecast News) - Contract preclinical antibody research provider Fusion Antibodies reported revenues of £2.4m in its first half on Monday, including a one-off milestone of £0.15m, which was up from £1.9m year-on-year.
The AIM-traded firm said underlying growth in revenues over the first half of the 2021 financial year came in at 20%.

Its loss for the period widened to £0.6m from £0.5m, while its cash position at period end on 30 September was £2m, compared to £2.7m at the end of March.

On the operational front, Fusion noted a "major" new 'RAMP' platform contract win in the period, with a minimum contract value of $1.83m over the next two years.

It also entered a collaboration with Eurofins Discovery to supply antibody development services, with the board adding that research and development projects were progressing "well" alongside its ongoing investment.

"We are delighted to report a strong all-round performance for the first half of the year with good revenue growth, major new contracts, collaboration agreements and increased investment into our research programmes," said chief executive officer Richard Jones.

"Throughout the period there have been continued challenges associated with the global pandemic and I would like to thank our staff for continuing to meet and overcome these as they arise, in support of the company and colleagues."

At 1113 GMT, shares in Fusion Antibodies were up 0.83% at 121p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

FAB Market Data

Currency UK Pounds
Share Price 55.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 142.50
52 Week Low 53.00
Volume 7,461
Shares Issued 26.01m
Market Cap £14.44m
RiskGrade 464

FAB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.21% below the market average30.21% below the market average30.21% below the market average30.21% below the market average30.21% below the market average
48.72% above the sector average48.72% above the sector average48.72% above the sector average48.72% above the sector average48.72% above the sector average
Price Trend
90.09% below the market average90.09% below the market average90.09% below the market average90.09% below the market average90.09% below the market average
75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average75.61% below the sector average
Income Not Available
Growth
31.04% above the market average31.04% above the market average31.04% above the market average31.04% above the market average31.04% above the market average
27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average

FAB Dividends

No dividends found

Trades for 27-May-2022

Time Volume / Share Price
13:57 3,633 @ 54.50p
11:57 2,000 @ 54.59p
10:35 1,815 @ 54.75p
09:53 3 @ 54.75p
09:09 10 @ 53.00p

FAB Key Personnel

Chair Simon Gordon Douglas
CFO James Alexander Fair

Top of Page